Wednesday, April 22, 2026
29.4 C
Bengaluru

Frontline Managers

[wpfilebase tag=file id=62 tpl=download-button /]

Inside this Issue

1. Parle-G: Still Number One by Vivek Hattangadi

How this 80 year old brand still has 80 percent market share.

2. The University of Pharma Sales by Raja Reddy

What the author learned about success and life on his journey from Medical Representative to Group Product Manager.

3. Nine Accountability Boosters for Frontline Managers by K. Hariram

9 habits that will inspire the confidence of your team members in your Leadership.

4. Bridging the Trust Deficit by Satish Kota

Indian Pharma has contributed immensely to society but needs an image makeover to change negative perceptions.

5. Impact of Frontline Leadership on Efficiency: A Case Study by P. S. Parameswaran

The actions of the Frontline Manager, more than anything else, has a direct impact on how employees perform.

6. Cost-Effective Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

7. Smart Pills by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, Mahendra Kumar Rai

Are ingestible sensors the next big thing in patient adherence?

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img